Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:47 pm Purchase | 2025-11-05 | 13D | LENZ THERAPEUTICS INC LENZ | RA CAPITAL MANAGEMENT L.P. | 4,265,106 13.600% | 4,500 (+0.11%) | Filing History |
| 2025-11-06 4:29 pm Sale | 2025-11-04 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 6,681,307 13.800% | -65,500 (-0.97%) | Filing History |
| 2025-11-03 4:42 pm Sale | 2025-10-30 | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -20,013,733 (Position Closed) | Filing History |
| 2025-10-30 6:42 pm Sale | 2025-10-28 | 13D | VOR BIOPHARMA INC VOR | RA CAPITAL MANAGEMENT L.P. | 810,671 11.500% | -375,829 (-31.68%) | Filing History |
| 2025-10-30 4:36 pm Purchase | 2025-10-23 | 13G | RANI THERAPEUTICS HLDGS INC CO RANI | RA CAPITAL MANAGEMENT L.P. | 9,882,477 9.900% | 9,882,477 (New Position) | Filing History |
| 2025-10-27 8:06 pm Sale | 2025-10-23 | 13D | VOR BIOPHARMA INC VOR | RA CAPITAL MANAGEMENT L.P. | 1,186,500 17.300% | -246,193 (-17.18%) | Filing History |
| 2025-10-27 4:07 pm Purchase | 2025-10-20 | 13G | LEXEO THERAPEUTICS INC LXEO | RA CAPITAL MANAGEMENT L.P. | 5,000,000 6.900% | 5,000,000 (New Position) | Filing History |
| 2025-10-24 4:13 pm Purchase | 2025-10-17 | 13G | C4 THERAPEUTICS INC CCCC | RA CAPITAL MANAGEMENT L.P. | 9,441,256 9.900% | 9,441,256 (New Position) | Filing History |
| 2025-10-20 6:58 pm Sale | 2025-10-16 | 13D | VOR BIOPHARMA INC VOR | RA CAPITAL MANAGEMENT L.P. | 1,432,693 20.900% | -555,964 (-27.96%) | Filing History |
| 2025-10-16 7:35 pm Purchase | 2025-10-08 | 13G | JADE BIOSCIENCES, INC. JBIO | RA CAPITAL MANAGEMENT L.P. | 3,214,969 7.000% | 1,890,015 (+142.65%) | Filing History |
| 2025-10-09 4:28 pm Purchase | 2025-10-02 | 13G | PALISADE BIO INC COM P PALI | RA CAPITAL MANAGEMENT L.P. | 9,935,761 9.900% | 9,935,761 (New Position) | Filing History |
| 2025-10-03 4:26 pm Purchase | 2025-09-26 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA CAPITAL MANAGEMENT L.P. | 4,401,500 9.900% | 4,401,500 (New Position) | Filing History |
| 2025-10-01 9:19 pm Purchase | 2025-09-29 | 13D | ARS PHARMACEUTICALS, INC SPRY | RA CAPITAL MANAGEMENT L.P. | 10,940,977 11.100% | 80,000 (+0.74%) | Filing History |
| 2025-09-30 4:36 pm Purchase | 2025-09-26 | 13D | PEPGEN INC PEPG | RA CAPITAL MANAGEMENT L.P. | 20,099,753 29.200% | 9,404,618 (+87.93%) | Filing History |
| 2025-09-19 4:53 pm Purchase | 2025-09-17 | 13D | VOR BIOPHARMA INC VOR | RA CAPITAL MANAGEMENT L.P. | 1,988,657 29.000% | 1,664 (+0.08%) | Filing History |
| 2025-09-19 4:47 pm Purchase | 2025-09-12 | 13G | LB PHARMACEUTICALS INC LBRX | RA CAPITAL MANAGEMENT L.P. | 1,675,000 7.500% | 1,675,000 (New Position) | Filing History |
| 2025-09-08 6:00 pm Purchase | 2025-09-04 | 13D | MINERALYS THERAPEUTICS INC MLYS | RA CAPITAL MANAGEMENT L.P. | 7,796,433 9.900% | 1,508,836 (+24.00%) | Filing History |
| 2025-08-29 4:32 pm Purchase | 2025-08-22 | 13G | INVIVYD, INC. IVVD | RA CAPITAL MANAGEMENT L.P. | 21,338,288 9.900% | 21,338,288 (New Position) | Filing History |
| 2025-08-26 4:59 pm Purchase | 2025-06-30 | 13G | ADAGIO MED INC ADGM | RA CAPITAL MANAGEMENT L.P. | 1,200,000 7.200% | 1,200,000 (New Position) | Filing History |
| 2025-08-20 4:41 pm Purchase | 2025-06-30 | 13G | CERVOMED INC CRVO | RA CAPITAL MANAGEMENT L.P. | 1,026,937 9.900% | 1,026,937 (New Position) | Filing History |